PCK, Author at PCK

Filter by
Categories
Tags
Show all

January 23, 2025

Elevate Your IP Strategy with Communitech’s ElevateIP Program

Communitech’s ElevateIP program provides financial support to Canadian startups to build and manage intellectual property portfolios. Funding can be used for IP strategy development, patent and trademark filings, and commercialization efforts, empowering businesses to drive innovation and unlock growth. Apply now.

December 13, 2024

CIPO Announces Pilot Project for Registrar-Initiated Summary Cancellation Proceedings of Registered Trademarks

Starting January 2025, Trademark owners in Canada are now subject to a new CIPO pilot project where the Registrar may issue Section 45 notices, requiring proof of use for trademarks registered over three years. Ensure your trademarks are protected by maintaining proper records of use.

December 4, 2024

CIPO Trademark Fee Increases Effective January 1, 2025: Key Updates

The Canadian Intellectual Property Office (CIPO) will implement its annual inflation-adjusted fee increases for trademarks under the Service Fees Act. The increase is 4.4%, across the board.

November 29, 2024

Trademark Scam Circulating – CPATA Advises Public Caution

North American businesses are the target of a new trademark phishing scam, prompting a detailed warning from the College of Patent Agents and Trademark Agents (CPATA). To stay protected, always verify the source and avoid responding to suspicious correspondence.

November 22, 2024

USPTO Patent Fee Increases Effective January 19, 2025: What You Need to Know

The USPTO has announced significant changes to its patent fee structure, effective January 19, 2025. Stay ahead by planning strategically to manage costs and filings effectively.

September 19, 2024

CPATA: Reflections and Updates from an Elected Director, Andrew Currier

Andrew Currier, CPATA Elected Director, reflects on recent developments in Canada's IP landscape, covering board transitions, regulatory updates and more!

November 25, 2019

Pharmacist in a white lab coat, holding bottles of pharmaceuticals.

November 25, 2019

Patent Strategy & Potential Changes to Patented Medicine Regulations & Drug Pricing Legislation

The rising cost of patented medicines is an important topic in the United States and Canada. In the United States, the White House is promising to...

February 11, 2015

Receiving Copyrighted Material Considered a Presumptive Connecting Factor in Seismic Data Dispute

Geophysical Service Incorporated v Arcis Seismic Solutions Corp, 2015 ABQB 88 - The Court analogized misuse of confidential information to copyright infringement to decide that the jurisdiction where the copyright-infringing material was received was also significant.

February 5, 2015

Federal Court Reverses Commissioner’s Opinion that Janssen Altered the Prohibition against Patenting of Methods of Medical Treatment

AbbVie Biotechnology Ltd v Canada (Attorney General), 2014 FC 1251 - The core of the Commissioner’s argument was that Janssen Inc v Mylan Pharmaceuticals ULC, 2010 FC 1123, broadened the prohibition against patents on methods of medical treatment to include generally claims which restrict the “how and when” a physician could administer a particular drug. The Court found that the Commissioner had misread Janssen.

February 3, 2015

ONCA Preserves Protection of Discussions between Expert Witnesses and Lawyers

Moore v Getahun, 2015 ONCA 55 - The Court referred to UK authorities that described patent law as an example of a highly technical area where “expert witnesses require a high level of instruction by the lawyers”, supposedly to liken the highly technical area of patent law to the highly technical area of medical malpractice with respect to its reliance on expert evidence.

January 27, 2015

TMOB Removes Investment Advice from Atticus’s List of Services

Atticus Canada Inc v Atticus Management LLC, 2014 TMOB 196 - Evidence of trade-mark use consisting of copies of license agreements allowing Atticus Capital LP to use the Mark was taken to demonstrate use in association with financial services generally, but not in association with investment advice.

January 23, 2015

Patent for using a Short Needle for Intradermal Delivery for Vaccinations Rejected for Obviousness

Commissioner’s Decision # 1371 - The Commissioner refused to grant GlaxoSmithKline’s patent application for an “influenza vaccine formulation for intradermal delivery” due to obviousness since there was always a motivation to use the ID route, but it had always been impractical until the advent of a short needle device.

January 20, 2015

SCOTUS Asks Solicitor General’s Advice on Whether to Hear Google’s Java API Copyright Case

Google, Inc v Oracle America, Inc, 14-410 - This case would put at issue whether Java’s method headers are subject to copyright protection, or whether they are excluded by Section 102(b) of the Copyright Act for being a system or method of operation.

January 13, 2015

Commissioner Finds Non-Invasive Virtual Reality Training System to be Inventive

Commissioner’s Decision # 1372 - The Patent Appeal Board reversed an examiner’s finding of obviousness for Canadian Patent Application No. 2,554,498, which discloses a virtual reality simulator for training users in the skill of welding.

January 8, 2015

Commissioner Approves eBay’s Automated Email Notification Patent

Commissioner’s Decision # 1369 - Two elements of the invention were found to be inventive: (1) the “push” process for keeping status information up-to-date, and (2) the automatic notification system that automatically sends an email message only when a delivery status has changed.

December 23, 2014

Bill C-8 Expands Counterfeit Goods Enforcement and Reworks the Trade-marks Act

Bill C-8 is said to broaden the enforcement measures available to protect copyright and trade-mark rights and to curtail commercial activity in counterfeit goods, and is said to expand the scope of what can be registered as a trade-mark and modernizes the trade-mark application and opposition process. Several definitional changes are also made to key terms in the Trade-marks Act.

December 22, 2014

Industry Canada to Amend PM(NOC) Regulations Respecting Patents Listed for Combination Drugs

The proposed amendments are said to clarify the patent listing requirements as they relate to single medicinal ingredients found in combination drugs and confirm Health Canada’s established practices which, in light of recent Federal Court and Federal Court of Appeal decisions, may need to change.

December 19, 2014

Section 52 of Patent Act used to Add Inventors to a Patent after an Omission due to Misunderstanding of Canadian Law

Dr Falk Pharma GMBH v Canada (Commissioner of Patents), 2014 FC 1117 - Pursuant to section 52 of the Patent Act, the Federal Court ordered that the Commissioner of Patents add Peter Gruber to the list of inventors for Canadian Patent No. 2,297,832. Dr. Falk Pharma GMBH, the applicant and owner of the patent, inadvertently omitted Gruber’s name from the list of inventors.

December 18, 2014

NSCA Draws Distinction Between Ordering Patent Assignment and Ordering a Transfer of Interest

Bardsley v Stewart, 2014 NSCA 106 - The Court found that the order was fair as it was merely ordering that Bardsley transfer his interests in the ‘770 Application to the extent possible, thus stopping just short of ordering assignment.

December 12, 2014

UK Court holds email file transfer program is unpatentable subject matter

Lantana Ltd v The Comptroller General of Patents, Design and Trade Marks, [2014] EWCA Civ 1463 - The UK Court rejected a patent on a method of transferring files via email communication for unpatentable subject matter for being no more than a computer program.